α4-Integrin Mediates Neutrophil-Induced Free Radical Injury to Cardiac Myocytes by Poon, Betty Y. et al.
 
ã
 
 The Rockefeller University Press, 0021-9525/2001/03/857/10 $5.00
The Journal of Cell Biology, Volume 152, Number 5, March 5, 2001 857–866
http://www.jcb.org/cgi/content/full/152/5/857 857
 
a
 
4
 
-Integrin Mediates Neutrophil-induced Free Radical Injury to
Cardiac Myocytes
 
Betty Y. Poon,* Christopher A.Ward,
 
i
 
 Conan B. Cooper,
 
‡
 
 Wayne R. Giles,
 
§
 
 Alan R. Burns,
 
¶
 
and Paul Kubes*
 
§
 
*Immunology Research Group, 
 
‡
 
Department of Pharmacology and Therapeutics, and 
 
§
 
Department of Physiology and Biophysics, 
 
University of Calgary, Calgary, Alberta T2N 1N4, Canada; 
 
i
 
Department of Physiology, Queen’s University, Kingston, Ontario K7L 
 
3N6, Canada; and 
 
¶
 
Department of Medicine, Section of Cardiovascular Sciences, Baylor College of Medicine, Houston, Texas 77030
 
Abstract. 
 
Previous work has demonstrated that cir-
culating neutrophils (polymorphonuclear leukocytes
 
[PMNs]) adhere to cardiac myocytes via 
 
b
 
2
 
-integrins
and cause cellular injury via the nicotinamide adenine
 
dinucleotide phosphate (NADPH) oxidase enzyme
system. Since PMNs induced to leave the vasculature
(emigrated PMNs) express the 
 
a
 
4
 
-integrin, we asked
whether (a) these PMNs also induce myocyte injury via
NADPH oxidase; (b) 
 
b
 
2
 
-integrins (CD18) still signal ox-
idant production, or if this process is now coupled to the
 
a
 
4
 
-integrin; and (c) dysfunction is superoxide depen-
dent within the myocyte or at the myocyte–PMN inter-
face. Emigrated PMNs exposed to cardiac myocytes
quickly induced signiﬁcant changes in myocyte function.
Myocyte shortening was decreased by 30–50% and
rates of contraction and relaxation were reduced by
30% within the ﬁrst 10 min. Both 
 
a
 
4
 
-integrin
 
 
 
antibody
(Ab)-treated PMNs and NADPH oxidase–deﬁcient
PMNs were unable to reduce myocyte shortening. An
increased level of oxidative stress was detected in myo-
cytes within 5 min of PMN adhesion. Addition of an
anti–
 
a
 
4
 
-integrin
 
 
 
Ab, but not an anti-CD18 Ab, pre-
vented oxidant production, suggesting that in emigrated
PMNs the NADPH oxidase system is uncoupled from
CD18 and can be activated via the 
 
a
 
4
 
-integrin. Addition
 
of exogenous superoxide dismutase
 
 
 
(SOD) inhibited all
parameters of dysfunction measured, whereas overex-
pression of intracellular SOD within the myocytes did
not inhibit the oxidative stress or the myocyte dysfunc-
tion caused by the emigrated PMNs. These ﬁndings
demonstrate that profound molecular changes occur
within PMNs as they emigrate, such that CD18 and as-
sociated intracellular signaling pathways leading to oxi-
dant production are uncoupled and newly expressed 
 
a
 
4
 
-
 
integrin functions as the ligand that signals oxidant
production. The results also provide pathological rele-
vance as the emigrated PMNs have the capacity to in-
jure cardiac myocytes through the 
 
a
 
4
 
-integrin–coupled
NADPH oxidase pathway that can be inhibited by ex-
tracellular, but not intracellular SOD.
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Introduction
 
Neutrophils (polymorphonuclear leukocytes [PMNs]
 
1
 
) in-
filtrate the postischemic myocardium and cause much of
the myocardial dysfunction associated with this condition
(Rossen et al., 1985; Dreyer et al., 1991; Hawkins et al.,
1996). Therefore, much emphasis has been placed on pre-
venting PMN recruitment in an attempt to minimize myo-
cardial injury. Reduction of circulating PMN numbers with
anti-PMN antibodies (Abs; Romson et al., 1983) or PMN
depletion filters (Engler et al., 1986) reduced infarct size in
hearts challenged by ischemia-reperfusion. Reducing the
recruitment of PMNs by immunosuppression of adhesion
molecules also limited myocardial injury (Lefer et al.,
1993, 1996; Tamiya et al., 1995; Zhao et al., 1997). Further-
more, experiments with complement depletion (Maroko et
al., 1978) and lipoxygenase inhibitors (Shappell et al.,
1990a), aimed at reducing PMN chemotactic factors, lim-
ited infarct size. Clearly, preventing the recruitment of
PMNs into myocardial tissue reduces injury. However,
once the PMNs leave the microvasculature, the molecular
interactions are less well understood. Although antiadhe-
sion therapy within the vasculature has received much at-
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2
 
9
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9
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tention, patients with postischemic reperfusion already
have PMN infiltration in the heart. This, coupled with the
fact that emigrated PMNs in contact with cardiac myocytes
are at least in part the injurious cells, emphasizes the im-
portance of studying PMN events outside the vasculature.
In fact, direct molecular contact between a PMN and myo-
cyte is absolutely required before myocyte dysfunction can
occur (Entman et al., 1990; Poon et al., 1999). Therefore,
understanding the molecular detail of PMN–myocyte in-
teractions may be key to effective therapeutic intervention
for this common cardiovascular condition.
In 1995, it was demonstrated that human PMNs that
transmigrated across endothelium expressed increased
surface levels of 
 
a
 
4
 
-integrin (Kubes et al., 1995). More re-
cently, both rat (Reinhart et al., 1997) and murine (Poon
et al., 1999) emigrated PMNs were also shown to express
increased levels of 
 
a
 
4
 
-integrin. Subsequent studies showed
that the 
 
a
 
4
 
-integrin was able to support adhesion of emi-
grated PMNs to cardiac myocytes, even after inhibition of
the 
 
b
 
2
 
-integrin, which is the dominant adhesion molecule
on circulating PMNs (Reinhart et al., 1997). After adher-
ing to the cardiac myocyte, emigrated PMNs reduced the
contractile responses of the myocytes to electrical stimula-
tion (Poon et al., 1999). Although in vivo inhibition of
known PMN products, including oxygen free radicals, pro-
teases, and arachidonic metabolites, reduces the extent of
myocardial injury (Bednar et al., 1985; Simpson et al.,
1987; Ma et al., 1992), to date the mechanisms by which
emigrated PMNs impair myocyte function are unclear.
In seminal studies, Smith and colleagues showed that
circulating PMNs adhered to cardiac myocytes via 
 
b
 
2
 
-inte-
grin (CD18) and then released oxidants which penetrated
the myocyte, causing intracellular oxidative stress and
myocyte death (Shappell et al., 1990b; Smith et al., 1991;
Entman et al., 1992). The release of oxidants was entirely
dependent on CD18, inasmuch as inhibition of this mole-
cule with a monoclonal Ab prevented both the release of
oxidants by PMNs and the subsequent myocyte death.
However, based on the fact that emigrated PMNs use the
 
a
 
4
 
-integrin to bind to cardiac myocytes and these are in
fact the cells (as opposed to circulating PMNs) that make
contact with myocytes, we asked the following questions.
(a) Are oxidants still the damaging molecules, even
though emigrated PMNs are more apt to degranulate and
release numerous proteins (Zimmerli et al., 1986)? (b)
Does the 
 
b
 
2
 
-integrin still signal oxidant production or is
this very important function now replaced by the newly
expressed 
 
a
 
4
 
-integrin? (c) Is superoxide radical (O
 
2
 
2
 
) re-
sponsible for the ensuing myocyte injury, and can O
 
2
 
2
 
 and
the dysfunction be inhibited within the myocyte or at the
PMN–myocyte interface? In this study, each of these is-
sues was addressed in a murine model where emigrated
PMNs were coincubated with isolated ventricular myo-
cytes from transgenic and knockout (KO) mice.
 
Materials and Methods
 
All experimental protocols were reviewed and approved by the University
of Calgary Animal Resource Center.
 
Unloaded Cell Shortening Experiments
 
Unloaded cell shortening measurements were recorded with isolated mu-
rine ventricular myocytes and glycogen-elicited emigrated PMNs as de-
scribed previously (Poon et al., 1999). In brief, myocytes were electrically
 
stimulated at threshold voltage plus
 
 
 
10% and baseline unloaded cell short-
ening measured. Emigrated PMNs (10
 
6
 
), prestimulated with 1% zymosan-
activated plasma (ZAP), were then added and allowed to adhere to the
myocytes, and cell shortening was measured for 10 min. An 
 
a
 
4
 
-integrin Ab
(R1-2, 10 
 
m
 
g/ml; BD PharMingen) was added to PMNs to ensure that im-
paired myocyte function was related to this integrin.
To evaluate the role of oxidants, emigrated nicotinamide adenine dinu-
cleotide phosphate (NADPH) oxidase–deficient PMNs (10
 
6
 
) were iso-
lated from mice with a nonfunctional allele for the gp91
 
phox
 
 subunit of the
cytochrome 
 
b
 
 (NADPH oxidase KO mice). PMNs from these mice are
completely unable to generate O
 
2
 
2
 
 or hydrogen peroxide (H
 
2
 
O
 
2
 
; Pollock
et al., 1995). Myocyte cell shortening measurements were performed in
the presence of either wild-type (WT) or NADPH oxidase–deficient emi-
grated PMNs (pretreated with 1% ZAP). In a second series of experi-
ments, myocytes were isolated from transgenic mice overexpressing en-
dogenous Cu/Zn-superoxide dismutase (SOD; Epstein et al., 1987).
Myocytes isolated from these mice show a 10-fold increase in intracellular
SOD expression (Wang et al., 1998). Cell shortening measurements were
performed in myocytes from WT (C57BL6) or SOD overexpressing trans-
genic mice in the presence and absence of WT emigrated PMNs (10
 
6
 
). An-
other series of cell shortening experiments was performed with exogenous
SOD (from bovine erythrocytes, 300 U/ml; Sigma-Aldrich) to determine if
extracellular SOD could alter significantly the emigrated PMN-induced
myocyte injury. In each experiment the number of PMN–myocyte interac-
tions was recorded. In no case was a myocyte recorded unless it had ad-
herent PMNs throughout the experiment.
 
Cytochrome c Reduction Assay
 
A cytochrome 
 
c
 
 reduction assay was used to measure the production of
O
 
2
 
2
 
 from suspensions of emigrated PMNs. In brief, PMNs (10
 
7
 
/ml) were
added to two cuvettes containing PBS with CaCl
 
2
 
 (1.19 mM), MgCl
 
2
 
 (0.54
mM), and cytochrome 
 
c
 
 (1.5 mM; Sigma-Aldrich). In one sample, SOD
(from bovine erythrocytes, 264 U/ml; Sigma-Aldrich) was added and both
samples were read at the same time in a spectrophotometer (model
U-2000; Hitachi) at 550 nm. Optical density differences between the two
samples were recorded on an online chart recorder (Johns Scientific, Inc.).
After 5 min of baseline measurements, 1% ZAP was added to both sam-
ples and optical density was recorded for an additional 10 min.
 
Single Cell Imaging for Oxidant Production
 
Isolated ventricular myocytes and emigrated PMNs were loaded with
fluorescent probe, 6-carboxy-2
 
9
 
,7
 
9
 
-dichlorodihydrofluorescein diacetate
di(acetoxymethyl ester) (DCFH, 1 
 
m
 
M for myocytes and 10 
 
m
 
M for
PMNs; Molecular Probes) in Tyrode’s buffer with probenecid (0.5 mM;
Sigma-Aldrich) for 15 min at room temperature. DCFH is oxidized to
highly fluorescent 2
 
9
 
,7
 
9
 
-dichlorofluorescein in the presence of free radi-
cals. DCFH is not specific for any one oxidant and therefore can only be
used as an overall indicator of oxidative stress within the cell (LeBel et al.,
1992; Carter et al., 1994; Zhu et al., 1994; Murrant et al., 1999). Myocytes
were allowed to adhere to a glass coverslip (which was sealed by vacuum
grease to the bottom of a plastic stage chamber) for 5 min at room temper-
ature. The chamber was clipped into a machined stage platform on an Ax-
iovert-135 inverted microscope (ZEISS) equipped with an oil immersion
FLUAR 100
 
3
 
/1.3 objective for single cell imaging (Murphy, 1999). A
Delta-Ram high speed illuminator (Photon Technologies International),
which consists of a 75-W Xenon arc and a computer-controlled random-
access wavelength monochromator, provided excitation light. Wave-
lengths were further selected before cell illumination by a dichroic filter
(Chroma Technology Corporation) mounted on a sliding apparatus under
the objectives. The cells were excited at 480 nm and emission was re-
corded at 510 nm. ImageMaster v1.4 software (Photon Technologies In-
ternational) allowed direct control of the camera, illumination, and data
acquisition. Digital images of emissions from selected fields were saved to
computer disk in sequential order for off-line analysis.
To ensure that the relaxed, evenly striated myocytes were indeed
healthy, single cell fluorescence intensities were recorded every 10 s for 5
min. Cells exhibiting an increase in fluorescence of 
 
.
 
10 raw intensity units
were assumed to be unhealthy and were excluded from the study. Emi-
grated PMNs (10
 
6
 
), prestimulated with 1% ZAP, were added to the myo-
cytes and fluorescence intensities were recorded every 10 s for 10 min.
Phase–contrast photos of the myocytes with adherent PMNs were re-
corded digitally. At the end of each experiment, H
 
2
 
O
 
2 
 
(50 
 
m
 
M; Fisher Sci-
entific) was added to the cells to ensure adequate loading of the cells with
DCFH. Upon addition of the H
 
2
 
O
 
2
 
, the fluorescent signal from all myo-
cytes included in this study resulted in saturation of the sensor (255 raw in-
tensity units). 
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Oxidative stress was first characterized in myocytes in the presence and
absence of emigrated PMNs where both cell types were from WT animals.
In addition, oxidative stress was measured in WT myocytes exposed to
NADPH oxidase–deficient PMNs. WT myocytes and PMNs were also coin-
cubated in the presence of exogenous SOD (300 U/ml) and myocytes from
SOD overexpressing mice were exposed to WT PMNs. Finally, to further
explore whether the oxidative stress detected within myocytes induced by
emigrated PMNs could be modulated by adhesion molecules, WT myocytes
and PMNs were coincubated with either an anti-CD18 Ab (2E6, 8 
 
m
 
g/ml;
Endogen) or an anti–
 
a
 
4
 
-integrin Ab (R1-2, 10 
 
m
 
g/ml; BD PharMingen).
 
Integrin Expression on PMNs
 
Flow cytometry was used to measure the expression of CD11b/CD18 and
 
a
 
4
 
-integrin on circulating and emigrated PMNs. Circulating or emigrated
murine PMNs were stimulated with ZAP (10 min at room temperature)
and then washed. Red blood cells were lysed and PMNs were simulta-
neously fixed in 1% formalin (15 min at room temperature) and then
washed. Primary Abs directed against their respective adhesion molecules
(CD11b, MK/170, 0.25 
 
m
 
g per tube; 
 
a
 
4
 
-integrin, R1-2, 1 
 
m
 
g per tube) were
added. After 30 min at room temperature, cells were washed and labeled
with FITC-conjugated goat anti–rat IgG (Cedar Lanes Laboratories, Ltd.)
for 
 
a
 
4
 
-integrin and FITC-conjugated goat anti–hamster IgG (Caltag Labo-
ratories) for CD11b. After 30 min at room temperature, cells were washed
and fluorescence was measured on a FACScan™ flow cytometer (Becton
Dickinson). Appropriate controls (no primary, an isotype control, and no
secondary Ab) were completed for each set of experiments.
Immunogold electron microscopy was also performed on emigrated
PMNs stimulated with 1% ZAP and labeled with either the rat anti–
mouse 
 
a
 
4
 
-integrin Ab (R1-2, 10 
 
m
 
g/ml) or isotype-matched control Ab
(rat IgG2b, 10 
 
m
 
g/ml) for 10 min at room temperature. After Ab labeling,
PMNs were fixed in PBS containing 0.05% glutaraldehyde for 10 min at
room temperature, blocked in PBS containing 5% fetal calf serum (PBS-
FCS) for 30 min, and then labeled with secondary goat anti–rat IgG conju-
 
gated to 12 nm colloidal gold (1:5 dilution in PBS-FCS; Jackson Immu-
noResearch Laboratories) for 60 min at room temperature. The cells were
then transferred to sodium cacodylate (0.05 M) buffer, refixed in 1% glu-
taraldehyde for 60 min, and postfixed in sodium cacodylate containing 1%
tannic acid (5 min) just before osmium postfixation. This was followed by
en bloc uranyl acetate staining (60 min), dehydration through ethanol, and
embedding in LX112 resin (Polysciences, Inc.). Ultrathin sections (80 nm)
were stained with uranyl acetate and lead citrate and viewed on a JEOL
200 CX electron microscope.
To quantitate 
 
a
 
4
 
-integrin labeling, leukocyte profiles were viewed at
200,000
 
3
 
 magnification and the numbers of gold particles associated with
the cell surface were counted. Cells examined included PMNs (
 
n
 
 
 
5
 
 20 for
 
a
 
4
 
-integrin and
 
 n 
 
5
 
 10 for control IgG2b), monocytes/macrophages (
 
n 
 
5
 
 8
for 
 
a
 
4
 
-integrin and
 
 n 
 
5
 
 9 for control IgG2b), and lymphocytes (
 
n 
 
5
 
 4 for
 
a
 
4
 
-integrin and
 
 n 
 
5
 
 3 for control IgG2b). Gold particle counts were ex-
pressed as number of gold particles per cell profile.
 
Statistical Analysis
 
All data are expressed as the arithmetic mean 
 
6 
 
SEM. Data were com-
pared between treatment groups using an ANOVA of raw data with the
Dunnett method for multiple comparisons between groups. Values of 
 
P 
 
,
 
0.05 are considered statistically significant.
 
Results
 
Emigrated PMNs Decrease Cell Shortening
via 
 
a
 
4
 
-Integrin
 
Fig. 1 A shows the pattern of shortening of a myocyte elec-
trically stimulated at 1 Hz and at a strength 10% above
threshold voltage. The cell shortens 14 
 
m
 
m, or 12% of its
Figure 1. (A) Representative unloaded cell
shortening traces from a murine ventricular myo-
cyte which was paced at threshold voltage
110%. (B) Recordings of unloaded cell shorten-
ing of a myocyte at baseline and in the presence
of emigrated PMNs with and without anti-CD18
(2E6, 8 mg/ml) or anti–a4-integrin Ab (R1-2, 10
mg/ml) at 5 min. 
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resting cell length, and then relaxes in the expected, repro-
ducible pattern. The responses over a 10-min period of
field stimulation remain completely unchanged (multiple
overlapping traces), suggesting no decline in function with
time. Fig. 1 B shows a representative record of cell short-
ening, where the addition of emigrated PMNs reduced cell
shortening by 50% and this decrease was not prevented by
an anti-CD18 Ab, but was completely inhibited in the
presence of the anti–
 
a
 
4
 
-integrin Ab.
The number of adherent PMNs to myocytes is also pro-
vided in Fig. 1 B. Approximately three PMNs adhered per
myocyte. Addition of either an anti-CD18 Ab alone or an
anti–
 
a
 
4
 
-integrin Ab alone did not reduce the number of
adherent myocytes. Tandem administration prevents PMN–
myocyte interactions (data not shown). Although the func-
tion of a myocyte was not studied unless at least one adher-
ent PMN was present, it is important to note that cellular
dysfunction was very similar regardless of the number of
PMNs that adhered. A single PMN could induce the same
amount of myocyte dysfunction as multiple PMNs.
 
Emigrated PMNs Induce Ventricular Myocyte 
Dysfunction via Reactive Oxidants
 
Emigrated PMNs from WT mice generated O
 
2
 
2
 
 levels of
1.46 
 
6 
 
0.12 fM/cell/min (
 
n
 
 
 
5
 
 4). This level is approximately
half of the levels produced by maximally stimulated human
circulating PMNs (West et al., 1983). Emigrated PMNs
from NADPH oxidase–deficient mice did not produce free
radicals. Results showed O2
2 levels below the detectable
limits of the assay in these cells (n 5 2) (Fig. 2 A). Cumula-
tive cell shortening data are shown in Fig. 2 B. Unloaded
cell shortening remains at baseline at 5 min in controls
(n 5 6). The addition of emigrated PMNs to the myocyte
caused z40% reduction in cell shortening within 5 min
(n 5 7, P , 0.05). This result was observed regardless of
whether one or many PMNs adhered to the myocyte. In
contrast, PMNs from NADPH oxidase–deficient mice did
not alter cell shortening patterns (96.8 6 8.9% of baseline,
n 5 6, P , 0.05 compared with PMN-only group). There
was no difference in adhesion efficiency to cardiac myo-
cytes between WT and NADPH oxidase–deficient PMNs,
as shown in the inset. Leaving the NADPH oxidase–defi-
cient PMNs bound to the myocytes for even 10 min still re-
vealed no impairment (data not shown).
Data summarizing the maximal rates of contraction and
relaxation of myocytes within these groups are shown in
Fig. 3. The maximal rate of contraction and relaxation re-
mained constant in the control group throughout the en-
tire 10-min experimental period (n 5 6, P 5 NS). The ad-
dition of WT emigrated PMNs decreased both contraction
and relaxation rates by z30% from baseline at 10 min
(n 5 6, P , 0.05). It is noteworthy that changes in the rate
of contraction and relaxation did not occur at 5 min of PMN
exposure, the time at which a decrease in cell shortening
was observed. PMNs from NADPH oxidase–deficient
mice did not alter either contraction or relaxation rates in
these myocytes. Late in most experiments, after exposure
Figure 2. (A) Superoxide production in PMNs from WT (n 5 4)
and NADPH oxidase KO mice (n 5 2). (B) Cumulative un-
loaded cell shortening in control (no PMNs, n 5 6; WT PMNs,
n 5 7; and NADPH oxidase KO PMNs, n 5 6) at 5 min. 1, P ,
0.05 between indicated groups.
Figure 3. Change in rates of (A) contraction (1dP/dt) and (B)
relaxation (2dP/dt) in myocytes under baseline conditions after
10 min in control (no PMNs, n 5 6; WT PMNs, n 5 7; and
NADPH oxidase KO PMNs, n 5 6). 1, P , 0.05 relative to re-
spective baseline.Poon et al. a4-Integrin Mediates Free Radical Myocyte Injury 861
to PMNs, myocytes also became dysrythmic. Specifically,
control myocytes alone showed no myocyte dysrythmia
(n 5 6), but the addition of WT PMNs caused five of the
seven myocytes recorded to become dysrythmic. When
PMNs from NADPH oxidase–deficient mice were added
to the myocytes, only one of the six myocytes in this group
showed any dysrythmia.
SOD Inhibits Dysfunction at the
PMN–Myocyte Interface
First, we examined whether intracellular SOD could pre-
vent the myocyte dysfunction. Patterns of unloaded cell
shortening in ventricular myocytes isolated from SOD
overexpressing mice are shown in Fig. 4. There was no dif-
ference in maximal cell shortening between WT and SOD
over-expressing myocytes under baseline conditions (n 5
4, P 5 NS). The addition of WT emigrated PMNs caused
z30–40% reduction in cell shortening at 5 min in both of
these myocyte groups. Prolonged exposure of both WT
and SOD myocytes to PMNs for 10 min revealed the same
pattern of dysfunction (data not shown). The addition of
WT PMNs caused z50% reduction in contraction and re-
laxation rates in both WT and SOD overexpressing myo-
cytes (data not shown). One important difference between
WT and SOD overexpressing myocytes was a lesser pro-
pensity for dysrythmia in the latter. Specifically, although
there was no dysrythmia recorded for WT or SOD myo-
cytes alone, the addition of WT PMNs caused dysrythmia
in three of the four WT myocytes, but only one of the five
SOD myocytes. This could not be explained by differences
in the number of adherent PMNs. As shown in Fig. 4, the
same number of PMNs adhered to myocytes regardless of
the magnitude of intracellular SOD.
Next, we examined whether exogenous application of
SOD could affect unloaded cell shortening (Fig. 5). Con-
trol myocytes (no PMNs) maintained cell shortening at
baseline levels after 5 min (n 5 4). The addition of PMNs
caused a 45% reduction in cell shortening in the absence
of SOD (n 5 4, P , 0.05). The addition of exogenous
SOD protected the myocytes from injury (cell shortening
at 97 6 3% of baseline at 5 min, n 5 3, P , 0.05). Addi-
tion of exogenous SOD to the emigrated PMNs did not
affect their adhesion efficiency to cardiac myocytes, as
shown in the inset. A similar pattern of cell shortening
was observed at 10 min of PMN exposure (data not
shown).
Control myocytes maintained both contraction and re-
laxation rates at baseline levels throughout the 10-min ex-
perimental period (data not shown). The addition of
PMNs alone caused a 40% reduction in contraction rate
and a 32% reduction in relaxation rate at 10 min. Exoge-
nous SOD prevented all PMN-induced decreases in con-
traction and relaxation rates. There was no dysrythmia re-
corded for myocytes alone (baseline conditions). The
addition of PMNs caused dysrythmia in all of the myocytes
studied. When exogenous SOD was present, none of the
myocytes recorded showed dysrythmia.
Figure 4. Unloaded cell shortening of control (WT myocyte only,
n 5 4), WT PMNs (WT Myocyte 1 WT PMN, n 5 4), SOD con-
trol (SOD myocyte only, n 5 4), and SOD Myocyte 1 WT PMNs
(n 5 5) at 5 min. 1, P , 0.05 between indicated groups.
Figure 5. Unloaded cell shortening for control (no PMNs, n 5 4),
PMNs (PMN only, n 5 4), and SOD treatment (PMN 1 SOD
300 U/ml, n 5 3) at 5 min. 1, P , 0.05 between indicated groups.The Journal of Cell Biology, Volume 152, 2001 862
NADPH Oxidase Is Coupled to the a4-Integrin
Fig. 6 consists of a phase–contrast image of a WT PMN ad-
hering to a myocyte, where both cells are loaded with
DCFH as an indicator of overall oxidative stress within the
cells. Fluorescent images at baseline, 5 min, and 10 min of
PMN exposure and a transmission image of the cells are
shown. Fluorescence in the ventricular myocyte is first de-
tected at the point of PMN attachment. With time, it then
spreads throughout the myocyte. Fig. 7 A shows fluores-
cence intensity changes at 5 min after PMN exposure.
Control myocytes showed a minimal increase in fluores-
cence (4.4 6 0.7 raw intensity units above baseline, n 5 5).
In contrast, the addition of WT PMNs caused a fivefold in-
crease in fluorescence intensity over myocyte-only con-
trols (n  5 4, P , 0.05). However, PMNs deficient in
NADPH oxidase did not increase fluorescence levels
above controls (n 5 5, P 5 NS from control). Similar pat-
terns were also seen at 10 min (data not shown).
In the presence of exogenous SOD, WT emigrated PMNs
could not induce an increase in fluorescence (Fig. 7 B). In-
deed, fluorescence levels of myocytes increased from 4.8 6
0.5 in controls (n 5 4) to 36.0 6 3.6 in the presence of PMNs
at 5 min (n 5 4, P , 0.05). The addition of exogenous SOD
completely inhibited this PMN-induced increase in fluores-
cence (n 5 4, P , 0.05 compared with PMN-only group).
Similar patterns were also seen at 10 min (data not shown).
In complete contrast, 10-fold higher levels of intracellular
SOD within SOD transgenic myocytes did not reduce the
PMN-induced increase in fluorescence (Fig. 7 B).
Fluorescence intensity changes of myocytes in the pres-
ence or absence of Abs are shown in Fig. 8. Myocyte con-
trols show minimal increase in fluorescence (5.2 6 1.8 raw
intensity units above baseline, n 5 5). The addition of em-
igrated PMNs caused fluorescence levels to increase to
31.7  6  9.1 intensity units above baseline (n 5 6, P , 0.05).
Addition of an anti-CD18 Ab still resulted in at least a
threefold increase in fluorescence over controls (n 5 6,
P 5 NS compared with PMN-only group). However, addi-
tion of an anti–a4-integrin Ab reduced fluorescence back
to control levels (5.3 6 2.0 units above baseline, n 5 4, P ,
0.05 compared with PMN-only group). Similar patterns
were also seen at 10 min (data not shown).
Circulating PMNs were able to cause dysfunction once
bound to myocytes, but both the PMN adhesion and there-
fore, not surprisingly, the dysfunction were completely in-
hibited by CD18 Ab (data not shown).
Emigrated PMNs Express a4-Integrin
Fig. 9 summarizes the degree of a4-integrin expression on
circulating versus emigrated PMNs. The data reveal a sig-
nificant rightward shift of a4-integrin expression after emi-
gration. Fig. 9 also shows CD11b expression on the surface
of emigrated PMNs and demonstrates high levels of fluo-
rescence. Although a direct quantitative comparison cannot
be made between the two adhesion molecules (due to po-
tentially different affinities of the Abs), the data do suggest
a much larger amount of surface CD11b than a4-integrin.
To further examine the amount of a4-integrin on the sur-
face of PMNs, immunogold staining was performed and the
results show that 0.8 6 0.2 gold particles/cell profile (80 nm
thick) were consistently found on PMNs, whereas mono-
cytes had approximately five times as much a4-integrin
(4.3 6 0.9 gold particles/cell profile) and lymphocytes had
approximately six times as much a4-integrin (5.3 6 2.6 gold
particles/cell profile). This clearly demonstrates that lym-
phocytes and monocytes do express significantly more a4-
Figure 6. Representative fluorescence images of an adherent WT PMNs (arrow) to a WT myocyte. (A) Phase–contrast photo, (B) im-
mediately after adhesion of PMNs to the myocyte, (C) after 5 min of adhesion, (D) after 10 min of adhesion, and (E) color bar.Poon et al. a4-Integrin Mediates Free Radical Myocyte Injury 863
integrin than PMNs. Nevertheless, in the nine PMNs exam-
ined with an isotype-matched control Ab, we observed no
gold particles bound to the surface. In fact, in the 22 cells
examined only l cell (a macrophage) had nonspecific bind-
ing (1 gold particle), suggesting that there is significant a4-
integrin on PMNs. The presence of this molecule on the
PMN surface is consistent with the view that this molecule
could mediate signaling of oxidant production.
Discussion
Previous work from our laboratory has shown that emi-
grated murine PMNs express the a4-integrin and use this
ligand to mediate PMN-induced myocyte damage (Poon
et al., 1999). The present results extend these findings by
showing, for the first time, that emigrated PMNs impair
the function (cell shortening) of cardiac myocytes through
an  a4-integrin–coupled free radical pathway. Adherent
emigrated PMNs, isolated from NADPH oxidase–defi-
cient mice, had no affect on the contractile responses of
the myocytes. Furthermore, the number of myocytes that
displayed signs of dysrythmia was dramatically reduced
when the PMNs could not generate free radicals. Al-
though all mammalian cells produce some antioxidants,
the PMN has the capacity to overwhelm this antioxidant
“shield” and quickly induce severe cellular injury. In this
study, we have found that overexpressing intracellular
SOD in the myocyte was not sufficient to protect the cell
from PMN-induced reductions in cell shortening, contrac-
tion, or relaxation rate. However, addition of extracellular
SOD entirely prevented these negative inotropic effects.
Our work demonstrates that the a4-integrin is coupled
to free radical production by emigrated PMNs. The addi-
tion of an anti–a4-integrin Ab completely inhibited oxi-
dant production (Fig. 8). That is, oxidant levels were at
control levels (myocyte only) even though PMNs contin-
ued to adhere to the myocyte via CD18. Previous work
had suggested that a circulating PMN binds to endothe-
lium via CD18 and this event induces oxidant production
(Smith et al., 1991). Our previous work showed that immu-
nosuppression of the a4-integrin, but not CD18, inhibited
all parameters of emigrated PMN-induced myocyte dys-
function (Poon et al., 1999) and, in this study, inhibited ox-
idative stress. Taken together, these data suggest that after
the PMN emigrates out of the vasculature, the CD18-
NADPH oxidase pathway becomes uncoupled and there-
after oxidant production requires the a4-integrin. These
results provide the mechanistic evidence to suggest that
a4-integrin on PMNs couples to NADPH oxidase to in-
duce myocyte dysfunction.
It is well documented that integrins are involved in cell
signaling events. Current models postulate that when
ligands are engaged, kinases bound to the cytoplasmic tail
of integrins can initiate signaling cascades within the cell
(Yamada and Miyamoto, 1995). Signaling through the a4-
Figure 7. (A) Change in fluorescence intensity from baseline for
control (no PMNs, n 5 5), WT PMNs (n 5 4), and NADPH oxi-
dase KO PMNs (n 5 5) at 5 min. 1, P , 0.05 between indicated
groups. (B) Change in fluorescence intensity from baseline for
control (no PMNs, n 5 4), PMNs (PMN only, n 5 4), SOD treat-
ment (PMN 1 SOD 300 U/ml; n 5 4), and SOD Myocyte 1 WT
PMNs (n 5 4) at 5 min. 1, P , 0.05 between indicated groups.
Figure 8. Change in fluorescence intensity from baseline for con-
trol (no PMNs, n 5 5), PMNs (PMN only, n 5 6), CD18 Ab
(PMN 1 anti-CD18 Ab 2E6, 8 mg/ml, n 5 6), and Alpha4 Ab
(PMN 1 anti-a4 Ab R1-2, 10 mg/ml, n 5 4) at 5 min. 1, P , 0.05
between indicated groups.The Journal of Cell Biology, Volume 152, 2001 864
integrin resulted in protein kinase C activation in murine
T cells (Tchilian et al., 1997), an event known to phosphor-
ylate a key protein (p47phox) in the NADPH oxidase com-
plex. Indeed, p47phox was phosphorylated by purified pro-
tein kinase C in a cell-free system (Kramer et al., 1988;
Majumdar et al., 1991; Pilloud-Dagher et al., 1992). p47phox
is a cytosolic protein with a Src homology 3 domain struc-
tural motif involved in specific molecular interactions dur-
ing signal transduction (de Mendez et al., 1997). p47phox is
critical for oxidase activation in intact cells and the Src ho-
mology 3 domain has been implicated in the assembly and
maintenance of the NADPH oxidase activity in PMNs (de
Mendez et al., 1996). Accordingly, it is possible that the
adhesion of emigrated PMNs to cardiac myocytes via the
a4-integrin caused protein kinase C activation within the
PMN and subsequent p47phox phosphorylation, and that
the multicomponent NADPH oxidase within the PMN can
then assemble, resulting in free radical production. Previ-
ously, the a4-integrin was thought to be expressed only on
nonneutrophilic leukocytes and since NADPH oxidase is
primarily associated with PMNs, the novel observation
that emigrated PMNs also express the a4-integrin led, in
this study, to the demonstration that signaling through the
a4-integrin induces oxidant production in these cells.
Although to date, the a4-integrin has been thought of as
primarily an adhesion molecule, our data suggest that it
also functions as an important signaling molecule. In fact,
the amount of a4-integrin found on the surface of PMNs is
significantly less than that found on monocytes and lym-
phocytes, where the a4-integrin is thought to be the domi-
nant adhesion molecule. Indeed, dual addition of both
anti-CD18 and anti–a4-integrin Ab was required to inhibit
emigrated PMN adhesion to myocytes (Reinhart et al.,
1997). Although the low level of a4-integrin raises some
concern about the feasibility of this molecule to function as
an adhesion molecule, it is conceivable that engagement of
a4-integrin may either rapidly mobilize or cluster more a4-
integrin on the PMN surface. Indeed, Alon and colleagues
have very recently documented subsecond induction of a4-
integrin on the leukocyte membrane (Grabovaky et al.,
2000). With this type of flexibility to express a4-integrin, it
is also possible that in the absence of ligand (as would be
the situation in our flow cytometry and immunogold bind-
ing assays) a4-integrin may be rapidly reinternalized, shed,
or simply not upregulated to the same degree as in the
presence of myocyte ligands. Finally, it is possible that en-
gagement of a4-integrin signals other adhesive pathways to
be induced. Indeed, a4-integrin engagement by vascular
cell adhesion molecule 1 enhances CD18-dependent adhe-
sion (Chan et al., 2000). Whether other adhesion pathways
are also upregulated remains unknown.
Our purpose was not to identify the molecular mecha-
nisms by which the PMN-derived oxidants injure myo-
cytes. Nevertheless, the results provide some meaningful
insights in this regard. In the mouse, as in humans, con-
tractility is regulated by numerous mechanisms within the
myocyte (Opie, 1992). Phasic contraction is predominately
controlled by the magnitude of calcium (Ca21) flux
through dihydropyridine-sensitive L-type Ca21 channels
on the sarcolemma, and the much larger subsequent Ca21-
induced Ca21 release from the sarcoplasmic reticulum
(Katz, 1992b). The rate of contraction (cell shortening) is
controlled through the magnitude of cytoplasmic Ca21
available for contraction and the rate of recycling of the
actin-myosin cross-bridges (Katz, 1992a). However, the
rate of relaxation is dependent on the rate of Ca21 re-
uptake through sarco(endo)plasmic reticulum Ca21-ATP-
ase2 (SERCA2) on the sarcoplasmic reticulum (Katz,
1992b). Since our data show that cell shortening is reduced
before any significant changes in rate of contraction or re-
laxation (Figs. 2 and 3), much of the initial oxidant-
induced injury appears to be targeting the myocyte at the
plasma membrane surface. It is possible that the oxidants
are affecting the fast inward current (Na1 channel) or the
slow inward current (Ca21 channel), which depolarize the
myocyte upon electrical stimulation. Since the intracellu-
lar level of both of these ions can alter mechanical activity
and [Ca21]i, an alteration in either ion channel could affect
the magnitude of Ca21 available for Ca21-induced Ca21 re-
lease, or result in Ca21 overload of the cell. The fact that
myocytes are still able to contract and relax, albeit at a
slower rate in the presence of emigrated PMNs, implies
that the cardiac cell is able to maintain its intracellular mi-
lieu at sufficient levels to avoid contracture. This argues
against massive nonspecific cell injury and suggests a more
subtle alteration in the control of the contractile machin-
ery of the myocyte.
Activated PMNs can produce several different O2
2-
derived species, including H2O2, hypochlorous acid, per-
oxynitrite, or hydroxyl radical (Halliwell and Gutteridge,
1984, 1986; Liu et al., 1997). At present, there is no fluores-
cent probe sufficiently specific for the detection of a single
oxidant species. Indeed, although some investigators have
used DCFH (the probe used in this study) as an H2O2 de-
tection system (Carter et al., 1994), others have demon-
strated that DCFH reacts with other oxygen species, in-
cluding nitric oxide and hydroxyl radical (LeBel et al.,
1992; Zhu et al., 1994; Murrant et al., 1999). We would pre-
dict from our measurement of O2
2
 production that a single
emigrated PMN might optimally release nanomolar levels
Figure 9. Mean fluorescence intensity of a4-integrin on the sur-
face of circulating and emigrated PMNs. Nonspecific binding was
essentially zero. For comparison we also provide mean fluores-
cence data for the CD11b integrin subunit. Each experiment was
run at least four times.Poon et al. a4-Integrin Mediates Free Radical Myocyte Injury 865
of oxidant into a myocyte, assuming a cellular volume of 1
ml. Since H2O2 oxidizes DCFH between 5 and 500 mM
(LeBel et al., 1992), or at least 100-fold higher than the
amount of H2O2 produced by PMNs in our system, it is
likely that DCFH was detecting some other oxidant. Since
SOD scavenges O2
2
 but does not affect H2O2 levels, yet
SOD prevents oxidation of DCFH in our system, it is
likely that we were not detecting H2O2 and that H2O2 was
not the toxic molecule. It is noteworthy that extracellular
SOD could inhibit both the oxidative stress and myocar-
dial dysfunction, whereas overexpression of SOD within
the myocyte, even at 10-fold supranormal levels, did not
inhibit either the oxidative stress or myocardial dysfunc-
tion. This would be consistent with the very restricted dif-
fusion capacity of O2
2 and supports the view that if the
toxic oxidant had penetrated the cell, its phenotype has al-
tered such that it is no longer inhibitable by intracellular
SOD. For example, it is plausible that a derivative of O2
2,
such as the combination of O2
2 and nitric oxide, caused
the negative inotropic responses in the myocytes seen af-
ter exposure to emigrated PMNs. Indeed, preliminary data
using inducible nitric oxide synthase–deficient mice have
suggested a role for nitric oxide in our model (Poon, B.Y.,
and P. Kubes, preliminary observations).
In conclusion, our results reveal that profound molec-
ular changes occur within PMNs as they emigrate, such
that CD18 and associated intracellular signaling pathways
leading to oxidant production are uncoupled and a4-inte-
grin functions as the ligand that predominantly signals oxi-
dant production. This may be an important brake prevent-
ing PMNs from producing oxidants until the a4-integrin
detection system is engaged. In fact, in a normal inflamma-
tory process the uncoupling of CD18 with the NADPH ox-
idase system may in part explain why oxidant release is
limited from PMNs until after the cell reaches the extra-
cellular space.
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